Description
In this episode of the Skincredible podcast, Dr. Lisa Swanson sits down with Kynlie and her parents to share their powerful journey with eczema. Together, they open up about the daily challenges of managing Kynlie’s skin condition, the emotional impact on the entire family, and the long road of trial and error in search of relief.
They discuss the importance of finding the right medical support and reflect on the treatments that made a meaningful difference, and some that didn’t—including Dupixent, the Aron regimen, Elidel, Zoryve, and finally Opzelura—which Kynlie describes as “a miracle” and a true “game changer.”
With honesty and heart, the family shares their setbacks, breakthroughs, and hard-earned lessons, offering encouragement to others navigating similar struggles. Today, they’re celebrating more than clearer skin—they’re embracing a happier, more confident child who can show up as her authentic self, no longer held back by eczema.
Keywords
eczema, treatment, families, patients, success stories, skin condition, pediatric dermatology, Opzelura, Elidel, Dupixent, Zoryve, Aron regimen, emotional impact, healthcare, skin health
Chapters
00:00 Welcome & Intro
01:13 Kynlie, Morgan, & Allyson’s Journey
03:19 Kynlie Referred to Dr. Swanson
04:10 Healthcare Burdens
06:29 Climate, Emotional Distress
08:21 Eczema and Sleep Disturbances
09:39 Helpless Feeling, Sadness, Costs of Eczema
12:26 Social Effects for Kynlie
13:36 Kynlie’s Hatred for Ointment & for Dupixent
15:50 Bluey Episode: Hospital
17:11 Itch Predominant Eczema & Opzelura
18:27 Game Changer
20:38 Parents Notice Changes in Kynlie
23:30 Families Hesitant to Treat Eczema
24:02 Advice for Parents
26:28 Opzelura Safety Warning
27:57 Giving Patients a Choice
28:26 Treatment Fatigue, Unique Snowflakes
29:28 Kynlie’s Exciting Adventure in Canada
30:20 Thank You and Goodbye
The information shared on this podcast is for educational purposes only and is not a substitute for personalized medical advice. Always consult your physician regarding your health.